BENEFIT PLANS (Details) (USD $) | 0 Months Ended | 3 Months Ended | 6 Months Ended | |
Jul. 01, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Aug. 31, 2009 |
Number of Options | ' | ' | ' | ' | ' | ' | ' |
Outstanding, beginning balance (in shares) | ' | ' | ' | ' | 4,458,000 | ' | ' |
Granted (in shares) | 750,000 | ' | ' | ' | 890,000 | ' | ' |
Exercised (in shares) | ' | ' | ' | ' | -589,000 | ' | ' |
Forfeited (in shares) | ' | ' | ' | ' | -122,000 | ' | ' |
Outstanding, ending balance (in shares) | ' | ' | 4,637,000 | ' | 4,637,000 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $2.25 | ' | ' | ' | ' | ' | ' |
Number of Options vested and expected to vest, net of estimated forfeitures (in shares) | ' | ' | 4,573,000 | ' | 4,573,000 | ' | ' |
Number of Options exercisable (in shares) | ' | ' | 1,088,000 | ' | 1,088,000 | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Outstanding, beginning balance (in dollars per share) | ' | ' | ' | ' | $3.48 | ' | ' |
Granted (in dollars per share) | ' | ' | ' | ' | $5.23 | ' | ' |
Forfeited (in dollars per share) | ' | ' | ' | ' | $8.27 | ' | ' |
Outstanding, ending balance (in dollars per share) | ' | ' | $3.87 | ' | $3.87 | ' | ' |
Options vested and expected to vest, net of estimated forfeitures, Weighted Average Exercise Price (in dollars per share) | ' | ' | $3.78 | ' | $3.78 | ' | ' |
Options exercisable, Weighted Average Exercise Price (in dollars per share) | ' | ' | $3.03 | ' | $3.03 | ' | ' |
Outstanding options, Weighted Average Remaining Contractual Term in Years | ' | ' | ' | ' | '4 years 4 months 13 days | ' | ' |
Outstanding vested and expected to vest, net of estimated forfeitures, Weighted Average Remaining Contractual Term in Years | ' | ' | ' | ' | '4 years 3 months 18 days | ' | ' |
Options exercisable, Weighted Average Remaining Contractual Term in Years | ' | ' | ' | ' | '2 years 2 months 19 days | ' | ' |
Options outstanding, Aggregate Intrinsic Value | ' | ' | $6,416,000 | ' | $6,416,000 | ' | ' |
Options vested and expected to vest, net of estimated forfeitures, Aggregate Intrinsic Value | ' | ' | 6,416,000 | ' | 6,416,000 | ' | ' |
Options exercisable, Aggregate Intrinsic Value | ' | ' | 1,928,000 | ' | 1,928,000 | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Common shares reserved for issuance (in shares) | ' | 7,500,000 | ' | ' | ' | ' | 4,500,000 |
Increase in common shares reserved for issuance (in shares) | ' | 3,000,000 | ' | ' | ' | ' | ' |
Share-based compensation expense | ' | ' | 1,255,000 | 10,020,000 | 3,873,000 | 10,506,000 | ' |
Unrecognized compensation cost, weighted-average period | ' | ' | ' | ' | '1 year 9 months 15 days | ' | ' |
Unrecognized compensation cost | ' | ' | ' | ' | ' | ' | ' |
Total | ' | ' | 6,681,000 | ' | 6,681,000 | ' | ' |
2014 | ' | ' | 2,021,000 | ' | 2,021,000 | ' | ' |
2015 | ' | ' | 2,645,000 | ' | 2,645,000 | ' | ' |
2016 | ' | ' | 1,437,000 | ' | 1,437,000 | ' | ' |
2017 | ' | ' | 578,000 | ' | 578,000 | ' | ' |
2009 Covisint LTIP | ' | ' | ' | ' | ' | ' | ' |
Number of Options | ' | ' | ' | ' | ' | ' | ' |
Exercised (in shares) | ' | ' | -589,389 | ' | ' | ' | ' |
Outstanding, ending balance (in shares) | ' | ' | 4,600,000 | ' | 4,600,000 | ' | ' |
Unrecognized compensation cost | ' | ' | ' | ' | ' | ' | ' |
Total | ' | ' | 6,519,000 | ' | 6,519,000 | ' | ' |
2014 | ' | ' | 1,982,000 | ' | 1,982,000 | ' | ' |
2015 | ' | ' | 2,559,000 | ' | 2,559,000 | ' | ' |
2016 | ' | ' | 1,400,000 | ' | 1,400,000 | ' | ' |
2017 | ' | ' | 578,000 | ' | 578,000 | ' | ' |
Cost of revenue | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Share-based compensation expense | ' | ' | 69,000 | 593,000 | 584,000 | 598,000 | ' |
Research and development | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Share-based compensation expense | ' | ' | 28,000 | 451,000 | 94,000 | 498,000 | ' |
Selling and marketing | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Share-based compensation expense | ' | ' | 341,000 | 3,989,000 | 946,000 | 4,036,000 | ' |
Administrative and general | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Share-based compensation expense | ' | ' | 817,000 | 4,987,000 | 2,249,000 | 5,374,000 | ' |
Stock options | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Expiration period | ' | ' | ' | ' | '10 years | ' | ' |
Stock options | Vesting schedule one, fifth anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 25.00% | ' | ' |
Stock options | Vesting schedule three, second anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 30.00% | ' | ' |
Restricted Stock Units (RSUs) | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Granted (in shares) | 182,193 | ' | ' | ' | ' | ' | ' |
Granted, Weighted Average Grant-Date Fair Value (in dollars per share) | $4.86 | ' | ' | ' | ' | ' | ' |
Restricted Stock Units (RSUs) | 2009 Covisint LTIP | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Non-vested RSU outstanding, ending balance (in shares) | ' | ' | 200,000 | ' | 200,000 | ' | ' |
Restricted Stock Units (RSUs) | First anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 33.30% | ' | ' |
Restricted Stock Units (RSUs) | Second anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 33.30% | ' | ' |
Restricted Stock Units (RSUs) | Third anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 33.30% | ' | ' |
Performance-based Stock Awards | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Non-vested RSU outstanding, ending balance (in shares) | ' | ' | 681,000 | ' | 681,000 | ' | ' |
Share-based compensation reversed due to cancellations | ' | ' | ' | -2,900,000 | ' | ' | ' |
Performance-based Stock Awards | 2009 Covisint LTIP | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Share-based compensation expense | ' | ' | 1,300,000 | ' | 3,900,000 | ' | ' |
Performance-based Stock Awards | Administrative and general | ' | ' | ' | ' | ' | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Share-based compensation expense | ' | ' | ' | -2,800,000 | ' | -2,500,000 | ' |
Compuware | ' | ' | ' | ' | ' | ' | ' |
Number of Options | ' | ' | ' | ' | ' | ' | ' |
Outstanding, beginning balance (in shares) | ' | ' | ' | ' | 472,000 | ' | ' |
Granted (in shares) | ' | ' | ' | ' | ' | ' | ' |
Exercised (in shares) | ' | ' | ' | ' | -48,000 | ' | ' |
Forfeited (in shares) | ' | ' | ' | ' | -61,000 | ' | ' |
Cancelled/expired (in shares) | ' | ' | ' | ' | -45,000 | ' | ' |
Outstanding, ending balance (in shares) | ' | ' | 318,000 | ' | 318,000 | ' | ' |
Number of Options vested and expected to vest, net of estimated forfeitures (in shares) | ' | ' | 312,000 | ' | 312,000 | ' | ' |
Number of Options exercisable (in shares) | ' | ' | 266,000 | ' | 266,000 | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Outstanding, beginning balance (in dollars per share) | ' | ' | ' | ' | $9.23 | ' | ' |
Exercised (in dollars per share) | ' | ' | ' | ' | $8.80 | ' | ' |
Forfeited (in dollars per share) | ' | ' | ' | ' | $9.89 | ' | ' |
Cancelled/expired (in dollars per share) | ' | ' | ' | ' | $10.17 | ' | ' |
Outstanding, ending balance (in dollars per share) | ' | ' | $9.03 | ' | $9.03 | ' | ' |
Options vested and expected to vest, net of estimated forfeitures, Weighted Average Exercise Price (in dollars per share) | ' | ' | $9.01 | ' | $9.01 | ' | ' |
Options exercisable, Weighted Average Exercise Price (in dollars per share) | ' | ' | $8.85 | ' | $8.85 | ' | ' |
Outstanding options, Weighted Average Remaining Contractual Term in Years | ' | ' | ' | ' | '1 year 5 months 19 days | ' | ' |
Outstanding vested and expected to vest, net of estimated forfeitures, Weighted Average Remaining Contractual Term in Years | ' | ' | ' | ' | '1 year 4 months 28 days | ' | ' |
Options exercisable, Weighted Average Remaining Contractual Term in Years | ' | ' | ' | ' | '11 months 5 days | ' | ' |
Exercised, Aggregate Intrinsic Value | ' | ' | ' | ' | 71,000 | ' | ' |
Options outstanding, Aggregate Intrinsic Value | ' | ' | 542,000 | ' | 542,000 | ' | ' |
Options vested and expected to vest, net of estimated forfeitures, Aggregate Intrinsic Value | ' | ' | 538,000 | ' | 538,000 | ' | ' |
Options exercisable, Aggregate Intrinsic Value | ' | ' | 506,000 | ' | 506,000 | ' | ' |
Options vested (in shares) | ' | ' | ' | ' | 19,333 | ' | ' |
Options vested, weighted average fair value (in dollars per share) | ' | ' | ' | ' | $5.74 | ' | ' |
Unrecognized compensation cost | ' | ' | ' | ' | ' | ' | ' |
Total | ' | ' | 162,000 | ' | 162,000 | ' | ' |
2014 | ' | ' | 39,000 | ' | 39,000 | ' | ' |
2015 | ' | ' | 86,000 | ' | 86,000 | ' | ' |
2016 | ' | ' | 37,000 | ' | 37,000 | ' | ' |
2017 | ' | ' | $0 | ' | $0 | ' | ' |
Compuware | Stock options | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Expiration period | ' | ' | ' | ' | '10 years | ' | ' |
Compuware | Stock options | Vesting schedule one, third anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 50.00% | ' | ' |
Compuware | Stock options | Vesting schedule one, fourth anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 25.00% | ' | ' |
Compuware | Stock options | Vesting schedule two | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 25.00% | ' | ' |
Award vesting period | ' | ' | ' | ' | '4 years | ' | ' |
Compuware | Stock options | Vesting schedule three, first anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 30.00% | ' | ' |
Compuware | Stock options | Vesting schedule three, third anniversary | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 40.00% | ' | ' |
Compuware | Restricted Stock Units (RSUs) | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' |
Award vesting rights, percentage | ' | ' | ' | ' | 25.00% | ' | ' |
Award vesting period | ' | ' | ' | ' | '4 years | ' | ' |
Shares | ' | ' | ' | ' | ' | ' | ' |
Non-vested RSU outstanding, beginning balance (in shares) | ' | ' | ' | ' | 182,000 | ' | ' |
Granted (in shares) | ' | ' | ' | ' | ' | ' | ' |
Released (in shares) | ' | ' | ' | ' | -152,000 | ' | ' |
Forfeited (in shares) | ' | ' | ' | ' | -18,000 | ' | ' |
Dividend equivalents, net (in shares) | ' | ' | ' | ' | ' | ' | ' |
Non-vested RSU outstanding, ending balance (in shares) | ' | ' | 12,000 | ' | 12,000 | ' | ' |
Granted, Weighted Average Grant-Date Fair Value (in dollars per share) | ' | ' | ' | ' | ' | ' | ' |
Dividend equivalents, net, Weighted Average Grant-Date Fair Value (in dollars per share) | ' | ' | ' | ' | ' | ' | ' |
Released, Aggregate Intrinsic Value | ' | ' | ' | ' | $1,514,000 | ' | ' |